Weili Liu is a counsel at LCC Partners Law Office. He is also the major contact person for LCC’s international clients.
Weili focuses on intellectual property, cross-border investment, venture capital and commercial litigation. With an engineering background, Weili has extensive experience providing solutions for technology companies as well as for start-up companies. In addition, Weili assists many clients in the service industry.
Before joining LCC, Weili had many years of experience with international law firms.

Richard A. Sterba, a Principal in Fish’s Washington, D.C. office, leads, manages and tries complex patent cases in district courts and the U.S. International Trade Commission (ITC). He has worked on nearly thirty Section 337 investigations, including more than a dozen trials and has received several accolades for his extensive ITC trial experience, including having been named a Law360 International Trade Rising Star and having been recognized by The Legal 500. Mr. Sterba’s background in physics and mathematics enables him to handle cases spanning a wide range of technologies including mobile phones, telecommunications, networking, digital signal processing, microprocessors, integrated circuits, display devices, semiconductors, memory, medical devices, and various mechanical and software inventions. He also has been involved in cases implicating various technical standards, and is experienced in handling the unique issues, such as FRAND requirements, associated with litigating standards-essential patents. Prior to joining Fish’s litigation group, he spent several years preparing and prosecuting patent applications.

Min Woo Park is an associate attorney in the Washington D.C., office of Fish & Richardson. After earning his doctorate from the University of Tokyo, Dr. Park started his career in patent law at a Japanese prosecution firm, drafting patent applications and responding to office actions from the Japanese Patent Office. Since he joined Fish in 2011, Dr. Park has shifted the focus of his practice to patent litigation, in particular Section 337 investigations at the ITC. Although trained as a biochemist, Dr. Park has handled cases involving diverse technical matters, including pharmaceuticals, medical devices, automotive components, mobile phones, telecommunications, and optical communication networks. Dr. Park has lived in four different countries and is fluent in English, Japanese, and Korean.

Timothy W. Riffe is a Principal in the Washington, D.C., office of Fish & Richardson. His practice emphasizes complex patent litigation in district courts and the U.S. International Trade Commission (ITC) and post-grant proceedings before the U.S. Patent Trial and Appeal Board (PTAB). Mr. Riffe also advises clients in strategic patent counseling and prosecution. At the ITC, Mr. Riffe is a first-chair litigator and has led numerous litigations to victory, his most recent being litigation lead and first-chair attorney for NEC Corporation. At the PTAB, Mr. Riffe has appeared in approximately 150 proceedings for both patent owners and petitioners across a multitude of technology areas. Mr. Riffe’s extensive litigation and prosecution/counseling experience combined with his post-grant practice allows Mr. Riffe to bring a wealth of knowledge across multiple disciplines within the intellectual property field to bear on his clients’ behalf. Mr. Riffe has received numerous accolades regarding his legal work, including, being named to IAM Patent 1000: The World’s Leading Patent Professionals for the past four years, including being named as a “Top PTAB Practitioner” and recommended for International Trade Commission and for Patent by IAM. He also has been distinguished as one of Washingtonian Magazine’s Top Lawyers, Intellectual Property in Washington, D.C.

Gwilym Attwell is a Principal in Fish & Richardson’s Delaware office, managing the local presence of Fish’s highly regarded patent prosecution and counseling practice. Mr. Attwell’s practice is focused on U.S. and foreign patent prosecution, opinion work, due diligence studies, and client counseling in the fields of biotechnology, medical devices, and pharmaceuticals. He also assists clients in the strategic development and monetization of internal patent portfolios, patent process implementation and the assessment of third-party IP collaborations. In addition, Mr. Attwell works with clients on post-grant proceedings, including inter partes review and post-grant review petitions, and general post-grant patent strategy. Mr. Attwell’s practice has been recognized for numerous accolades including being listed on “The World’s Leading Patent